本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

10.19
-0.5300-4.94%
盤前10.190.00000.00%05:53 EDT
成交量:209.86萬
成交額:2,166.01萬
市值:22.31億
市盈率:-7.21
高:10.89
開:10.80
低:10.13
收:10.72
52周最高:16.44
52周最低:6.23
股本:2.19億
流通股本:1.85億
量比:0.86
換手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-1.4140
每股收益(LYR):-1.4203
淨資產收益率:-72.99%
總資產收益率:-34.95%
市淨率:4.29
市盈率(LYR):-7.17

資料載入中...

2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/05

重要事件披露

Form 8-K - Current report
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/05

重要事件披露

Form 8-K - Current report
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities